These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 9259094)
1. Future therapies for the treatment of bladder neoplasms. See WA; Berman CJ Semin Surg Oncol; 1997; 13(5):376-88. PubMed ID: 9259094 [TBL] [Abstract][Full Text] [Related]
3. Treatment of superficial carcinoma of the bladder. Paulson DF Prog Clin Biol Res; 1984; 162B():193-209. PubMed ID: 6209720 [No Abstract] [Full Text] [Related]
4. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 3-2004. A 57-year-old man with invasive transitional-cell carcinoma of the bladder. Kaufman DS; Shipley WU; McDougal WS; Young RH N Engl J Med; 2004 Jan; 350(4):394-402. PubMed ID: 14736932 [No Abstract] [Full Text] [Related]
8. A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer. Scher HI J Urol; 1994 Aug; 152(2 Pt 1):574-5. PubMed ID: 8015114 [No Abstract] [Full Text] [Related]
9. Management of high-risk non-muscle invasive bladder cancer. Brausi M; Olaru V Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212 [TBL] [Abstract][Full Text] [Related]
15. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer. Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929 [TBL] [Abstract][Full Text] [Related]
16. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies. Zhang M; Tao R; Zhang C; Shen Z Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377 [TBL] [Abstract][Full Text] [Related]
17. [Usefulness of radiotherapy in the treatment of infiltrating bladder cancer]. Escudero Barrilero A Arch Esp Urol; 1990; 43 Suppl 2():165-84. PubMed ID: 1710884 [No Abstract] [Full Text] [Related]
18. T1G3: What to do? Mandressi A Arch Ital Urol Androl; 1996 Feb; 68(1):5-7. PubMed ID: 8664922 [No Abstract] [Full Text] [Related]
19. [Bladder tumors (transitional cell carcinoma)]. Matsumoto K Gan No Rinsho; 1989 Jan; Spec No():430-41. PubMed ID: 2915492 [No Abstract] [Full Text] [Related]
20. Selective organ preservation for the treatment of muscle-invasive transitional cell carcinoma of the bladder: a review of current and future perspectives. Hafeez S; Huddart R Expert Rev Anticancer Ther; 2014 Dec; 14(12):1429-43. PubMed ID: 25263197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]